Glucosylceramidase activity in fibroblasts from the E326K homozygous Parkinson’s disease case was also significantly reduced compared with controls, at a level intermediate between Gaucher disease, Parkinson’s disease with GBA mutation and non-manifesting carrier. This evidence concerns the gene GBA1 and Gaucher disease.